Dairy Feeds, Inc.
Letter data
- Company
- Dairy Feeds, Inc.
- Recipient
- Ms. Brenda Godwin | General Manager | Dairy Feeds, Inc. | P.O. Box 1365 | Okeechobee | , | FL | 34973-1365 | United States | dairyfeeds@embarqmail.com
- Issue date
- 2024-07-08
- Posted date
- Not available
- FDA office
- Division of Human and Animal Food Operations East IV
- Subject
- Not available
- Product
- Animal & Veterinary
- CMS ID
- 625951
- Reference number
- 24-HAFE4-WLCOL-07
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Dairy Feeds, Inc.
MARCS-CMS 625951 —
July 08, 2024
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Reference #:
24-HAFE4-WLCOL-07
Product:
Animal & Veterinary
Recipient:
Recipient Name
Ms. Brenda Godwin
Recipient Title
General Manager
Dairy Feeds, Inc.
P.O. Box 1365
Okeechobee
,
FL
34973-1365
United States
dairyfeeds@embarqmail.com
Issuing Office:
Division of Human and Animal Food Operations East IV
United States
Secondary Issuing Offices
United States
Dear Ms. Brenda Godwin:
The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter, 22-HAFE4-WL-06, dated July 27, 2022. Based on our evaluation It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Pearl E. Lopina -S
Pearl Lopina
Director of Compliance Branch
Content current as of:
07/17/2024
Regulated Product(s)
Animal & Veterinary